(DNLI) Denali Therapeutics - Performance -37.1% in 12m
DNLI performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-60.85%
#87 in Peer-Group
Rel. Strength
13.93%
#6596 in Stock-Universe
Total Return 12m
-37.12%
#107 in Peer-Group
Total Return 5y
-41.48%
#57 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 31.58 USD |
| 52 Week Low | 11.47 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 57.23 |
| Buy/Sell Signal +-5 | -1.74 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: DNLI (-37.1%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: DNLI vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for DNLI
| Total Return (including Dividends) | DNLI | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -4.41% | 3.15% | 4.01% |
| 3 Months | 14.33% | 17.08% | 17.14% |
| 12 Months | -37.12% | -11.14% | 13.46% |
| 5 Years | -41.48% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | DNLI | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 9.5% | 52.1% | 90.3% |
| 3 Months | 15.6% | 79.4% | 97.5% |
| 12 Months | -81.1% | -87.4% | 46.4% |
| 5 Years | -83.7% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th36.00 | -7.33% | -8.10% |
| 3 Month | %th41.50 | -2.35% | -2.40% |
| 12 Month | %th47.50 | -29.23% | -44.58% |
| 5 Years | %th73.50 | -25.01% | -72.49% |
FAQs
Does Denali Therapeutics (DNLI) outperform the market?
No,
over the last 12 months DNLI made -37.12%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months DNLI made 14.33%, while XBI made 17.08%.
Performance Comparison DNLI vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
DNLI vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.4% | -8.4% | -33.8% | -51% |
| US NASDAQ 100 | QQQ | 1.5% | -8.6% | -35.8% | -50% |
| German DAX 40 | DAX | 1.1% | -5.6% | -45.9% | -67% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.2% | -9% | -38.2% | -56% |
| Hongkong Hang Seng | HSI | 0.5% | -7.2% | -55.8% | -72% |
| India NIFTY 50 | INDA | 2.8% | -3.6% | -34.2% | -34% |
| Brasil Bovespa | EWZ | 5.6% | -3.8% | -48.8% | -38% |
DNLI vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.8% | -6.1% | -37.1% | -61% |
| Consumer Discretionary | XLY | 0.5% | -7.8% | -26.1% | -55% |
| Consumer Staples | XLP | 3.5% | -4.3% | -32.8% | -45% |
| Energy | XLE | -1.5% | -8.5% | -26.2% | -39% |
| Financial | XLF | 2.9% | -7% | -36.1% | -62% |
| Health Care | XLV | 1.3% | -4.5% | -22.3% | -30% |
| Industrial | XLI | 1% | -8.9% | -39.6% | -61% |
| Materials | XLB | 0.8% | -8.9% | -34.4% | -41% |
| Real Estate | XLRE | 1.7% | -4.3% | -32.3% | -45% |
| Technology | XLK | 1.5% | -11% | -38.9% | -48% |
| Utilities | XLU | 1.4% | -7% | -37.8% | -57% |
| Aerospace & Defense | XAR | 0.8% | -11.3% | -53.8% | -86% |
| Biotech | XBI | -2.2% | -7.6% | -23.5% | -26% |
| Homebuilder | XHB | -1.7% | -13.2% | -27.2% | -36% |
| Retail | XRT | 1.5% | -7.7% | -29% | -43% |
DNLI vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.8% | -7.71% | -19.9% | -33% |
| Natural Gas | UNG | 3.2% | 2.1% | -7.8% | -35% |
| Gold | GLD | 1.3% | -4.7% | -51.7% | -76% |
| Silver | SLV | -2.9% | -10.7% | -55.8% | -59% |
| Copper | CPER | -8.9% | -19.4% | -53.3% | -61% |
DNLI vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.3% | -4.4% | -28.5% | -33% |
| iShares High Yield Corp. Bond | HYG | 2% | -5.5% | -30.8% | -46% |